In the current economic and political environment, import substitution is one of the key drivers of the Russian pharmaceutical market. Soon, we can expect more than 70 Russian alternatives to 30 INNs out of the 57 strategically important pharmaceutical drugs alone. RNC Pharma presents the results of the research of import substitution and localization in the Russian pharmaceutical market...

On March 26, Moscow hosted a Russian Association of Pharmaceutical Marketing (RAPM) conference, “New Threats and Opportunities of Russian Pharmaceutical Market in 2015”. Within the agenda of the conference, RNC Pharma published a forecast of the Russian pharmaceutical market after the monetary crisis of 2014-2015...